$SKHY

SK Hynix Approved $38 Billion of New Memory Fabs That Won't Produce a Chip Before December 2028

SK Hynix (SKHY) said its board approved 54.3 trillion won (about $38B) for two new memory fabs. Y2 in Yongin will make HBM and next-gen DRAM, with first cleanroom opening in June 2029. M17 in Cheongju will make NAND, with first cleanroom opening in Dec 2028. The article cites Q2 revenue of 79.3T won and operating profit of 60.5T won.

Original reporting
Published Aug 15, 2026, 6:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 15, 2026, 6:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SK Hynix Approved $38 Billion of New Memory Fabs That Won't Produce a Chip Before December 2028 — source image
Decision brief

The 30-second read

$SKHYBullishMed
01

Why it matters

The key trading variable is the gap between approving capacity and when it can produce, which the article frames as potentially the most important number for memory pricing. It also ties the capex to recent strong demand and record profitability, while noting that current customer demand exceeds supply capabilities.

02

Market read

Investors may reprice memory supply tightness duration based on the delayed production start dates, affecting SK Hynix and broader memory pricing expectations.

03

What to watch

The article notes supply relief before 2029 must come from already-in-motion fabs and upgrades, so the incremental impact of these two new plants may be less immediate than the headline suggests.

Relevance 7/10Novelty 7/10Timing: today, post-approval capex and supply-timing read-through

Background

SK Hynix’s board approved two large memory-fab projects, one for HBM/next-gen DRAM (Y2) and one for NAND flash (M17), with multi-year construction and cleanroom timelines.

Company-level read

Ticker impact

$SKHYBullishMedium confidence
Context

SK Hynix approved 54.3 trillion won of new memory fab spending, with first cleanrooms not opening until Dec 2028 and Jun 2029.

Expected impact

Near-term bias positive for SK Hynix as the market may price in prolonged supply tightness; upside may be tempered by execution and demand-cycle risk.

Evidence & confidence

The article’s newest concrete facts are the board-approved capex amounts and the cleanroom opening timelines, which directly affect the supply ramp schedule and therefore pricing expectations.

Market effects

Reinforces the view that HBM and NAND supply tightness may persist longer than typical cycle expectations, potentially lifting sector pricing assumptions.

Could influence broader Korea semiconductor sentiment as investors reprice memory supply timelines.

May affect AI infrastructure supply expectations for HBM/DRAM and NAND lead times through 2028-2029.

Counterpoint

Delayed cleanroom openings do not guarantee sustained pricing power; demand could cool before the new capacity contributes, compressing margins.

Key entities

  • SK Hynix

    Approved $38B of new memory-fab capex split between Y2 (HBM/next-gen DRAM) and M17 (NAND), with first cleanrooms opening in 2028-2029.

Related articles

$SKHYMed

SK hynix ADR Joins Major U.S. and Korean ETFs

SK hynix's ADR (SKHY) was added to major U.S. and Korean ETFs, including the MVIS U.S. Listed Semiconductor 25 Index and VanEck's SMH ETF, with a 4.8% weight. This inclusion is expected to drive about $3.36 billion in capital inflows from the SMH ETF alone. The price disparity between the ADR and the domestic stock is also under focus, with a 39.2% difference as of Sept. 18.

$INTCHigh

Intel Climbs as SK Hynix Talks and Technical Signals Fuel Optimism — BigGo Finance

Intel (INTC) shares rose over 1% in premarket trading after reports of potential discussions with SK Hynix (SKHY) about producing memory chips in the U.S. The stock closed at $108.80 on Thursday, up 7.67%, with analysts adjusting ratings and price targets. Intel's stock is above key moving averages, and momentum indicators suggest buying pressure. The company is a significant holding in several ETFs, including SOXX and XNTK.

$SKHYMed

SK Hynix (SKHY) Stock Jumps 5% on U.S. Expansion News and Intel Partnership Discussions

SK Hynix shares rose 5.6% in Korea and 4.6% in U.S. premarket trading after announcing potential U.S. manufacturing expansions. Solidigm, its U.S. unit, is evaluating a NAND flash plant in New York, while SK Hynix discusses memory chip production with Intel in Ohio. The company leads the HBM market with 50% share and is building a $4B Indiana complex. Analysts rate SKHY a Strong Buy with a $249.70 price target, implying 36.5% upside.

$SKHYMed

SK Hynix explores Japan JV for AI memory expansion

SK Hynix (NASDAQ: SKHY) is exploring a joint venture or acquisition in Japan to expand AI memory chip production. Chairman Chey Tae-won confirmed site evaluations, while a source suggested a potential co-investment. The move aligns with SK Hynix's goal to capture AI demand and manage costs. The company holds a 14% stake in Kioxia and leads the HBM market with 58% revenue share in Q1 2026. SK Hynix plans to start HBM4E chip production in Indiana in Q3 2029, supported by $458 million in CHIPS Act

$SKHYHighAI 8/10

The HBM Pricing Cycle That Will Define SKHQ in 2026

SKHQ, a 2x inverse ETF tracking SK Hynix (SKHY), surged as SKHY reported record Q2 2026 revenue of KRW 79.32T, up 256.8% YoY. A potential HBM price decline could drop SKHY 15-25%, benefiting SKHQ. SKHQ's structure may erode value in sideways markets, with SKHY's high beta accelerating decay.